Cantón R
Hospital Universitario Ramón y Cajal, Madrid, Spain.
Clin Microbiol Infect. 2005 Apr;11 Suppl 1:3-8. doi: 10.1111/j.1469-0691.2005.01081.x.
Surveillance is usually defined as the ongoing and systematic collection, analysis and interpretation of health data essential to the planning, implementation and evaluation of public health practice. During recent years, most of these programmes have been developed in the field of antimicrobial resistance and nosocomial infections, but efforts have also been made in other areas. Recent experiences of emerging microbial threats, including severe acute respiratory syndrome and new influenza variants affecting humans, the re-emergence of infectious disease problems and the possibility of bioterrorism have evidenced the need for implementation of infectious disease surveillance programmes. clinical microbiology laboratories play a pivotal role in these programmes. They have the first opportunity to detect these problems and should participate in the design of reporting strategies and dissemination of this information. Policies for the flow of data to national and international authorities should be established using passive surveillance strategies. However, active surveillance programmes taking advantage of new methodologies, including virtual tools and mathematical programs, should be the goal for early detection of unusual patterns of microbial pathogens, outbreaks and healthcare-associated infections. In addition, early implementation of response strategies should be designed and performed with the cooperation of microbiology laboratories, and intervention and response protocols should be defined with the participation of clinical microbiologists.
监测通常被定义为对公共卫生实践的规划、实施和评估至关重要的健康数据进行持续且系统的收集、分析和解读。近年来,这些项目大多是在抗菌药物耐药性和医院感染领域开展的,但在其他领域也做出了努力。包括严重急性呼吸综合征和影响人类的新型流感变种在内的新出现的微生物威胁、传染病问题的再度出现以及生物恐怖主义的可能性等近期经历,都证明了实施传染病监测项目的必要性。临床微生物实验室在这些项目中发挥着关键作用。它们有首次检测到这些问题的机会,并且应该参与报告策略的设计和此类信息的传播。应采用被动监测策略来制定向国家和国际当局的数据流动政策。然而,利用包括虚拟工具和数学程序在内的新方法的主动监测项目,应该成为早期发现微生物病原体异常模式、疫情和医疗保健相关感染的目标。此外,应在微生物实验室的合作下设计并实施早期应对策略,并且应在临床微生物学家的参与下确定干预和应对方案。